HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiyasu Shimomura Selected Research

Drug Therapy (Chemotherapy)

10/2011Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiyasu Shimomura Research Topics

Disease

5Neoplasms (Cancer)
10/2011 - 06/2009
1Retinoblastoma (Glioblastoma, Retinal)
04/2010
1Glioma (Gliomas)
04/2010
1Chromosomal Instability (Chromosome Stability)
01/2010
1Carcinogenesis
01/2010

Drug/Important Bio-Agent (IBA)

3Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2011 - 06/2009
2Biomarkers (Surrogate Marker)IBA
08/2011 - 06/2009
1NF-kappa B (NF-kB)IBA
10/2011
1Phosphotransferases (Kinase)IBA
10/2011
1Caspase 3 (Caspase-3)IBA
08/2011
1Retinoblastoma ProteinIBA
04/2010
1Bromodeoxyuridine (BrdU)IBA
04/2010
1Aurora Kinase AIBA
01/2010
14- (3- chloro- 2- fluorophenoxy)- 1- ((6- (1,3- thiazol- 2- ylamino)pyridin to 2-yl)methyl) cyclohexanecarboxylic acidIBA
01/2010
1Histones (Histone)IBA
01/2010
1taxaneIBA
01/2010

Therapy/Procedure

3Therapeutics
04/2010 - 06/2009
1Drug Therapy (Chemotherapy)
10/2011